Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
61 hedge funds and large institutions have $46.3M invested in Histogen Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 28 closing their positions.
194% more call options, than puts
Call options by funds: $922K | Put options by funds: $314K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 19
16% less funds holding
Funds holding: 73 → 61 (-12)
35% less capital invested
Capital invested by funds: $71.7M → $46.3M (-$25.3M)
39% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$3.57M |
| 2 |
Goldman Sachs
New York
|
+$1.38M |
| 3 |
CM
Crestline Management
Fort Worth,
Texas
|
+$1.05M |
| 4 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$741K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$531K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.67M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.94M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.55M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.4M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$1.06M |
HSTO Hedge Fund Activity: Q2 2018 in Review
61 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2018, worth a combined $46.3M — down 35% from $71.7M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of HSTO and 17 opened new positions — a net loss of 11 holders — while 19 trimmed existing stakes and 17 added.
The largest buyer was Sofinnova Investments, opening a new position worth an estimated $3.57M. The largest seller was BlackRock, cutting an estimated $3.67M.
- 61 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2018, down from 73 in Q1 2018.
- Funds reported $46.3M of Histogen Inc. Common Stock stock for Q2 2018, down 35% quarter-over-quarter.
- 17 funds opened new Histogen Inc. Common Stock positions in Q2 2018 and 28 closed out, a net change of -11 holders.
- The largest Histogen Inc. Common Stock buyer in Q2 2018 was Sofinnova Investments, an estimated $3.57M added.
- The largest Histogen Inc. Common Stock seller in Q2 2018 was BlackRock, an estimated $3.67M sold.
Based on aggregated 13F filings for Q2 2018.